HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate

an Akt inhibitor; antineoplastic agent
Also Known As:
1L-6-hydroxymethyl-chiro-inositol 2-O-methyl-3-O-octadecylcarbonate; HCIMOC cpd; LY 294005; LY-294005; LY294005
Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sawaya, Raymond: 1 article (10/2007)
2. Mills, Gordon B: 1 article (10/2007)
3. Kondo, Yasuko: 1 article (10/2007)
4. Iwado, Eiji: 1 article (10/2007)
5. Fujiwara, Keishi: 1 article (10/2007)
6. Kondo, Seiji: 1 article (10/2007)
7. Fedier, Andre: 1 article (11/2006)
8. Boulikas, Teni: 1 article (11/2006)
9. Fink, Daniel: 1 article (11/2006)
10. Erdmann, Ruediger: 1 article (11/2006)

Related Diseases

1. Neoplasms (Cancer)
2. Adenocarcinoma
3. Glioma (Gliomas)

Related Drugs and Biologics

1. A-Form DNA (A-DNA)
2. Proteins (Proteins, Gene)
3. Platinum
4. Cisplatin (Platino)
5. lipoplatin
6. Epidermal Growth Factor Receptor (EGF Receptor)